Hangzhou Tigermed Consulting Cash Flow-to-Debt Ratio
Hangzhou Tigermed Consulting cash flow-to-debt ratio. Hangzhou Tigermed Consulting (300347) has a Cash Flow-to-Debt Ratio of 0.12x as of September 2025, meaning its operating cash flow of CN¥475.40 Million could theoretically repay 0% of its total liabilities (CN¥4.08 Billion) in one year. Check how high is Hangzhou Tigermed Consulting's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hangzhou Tigermed Consulting (2009–2025)
Cash flow-to-debt ratio of Hangzhou Tigermed Consulting from 2009 to 2025. Historical debt coverage capacity for Hangzhou Tigermed Consulting across 17 annual periods. Check 300347 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Hangzhou Tigermed Consulting Cash Flow-to-Debt Ratio by Year (2009–2025)
Hangzhou Tigermed Consulting cash flow-to-debt ratio by year from 2009 to 2025. Year-by-year debt coverage analysis for Hangzhou Tigermed Consulting. For the full cash flow conversion analysis, see how efficiently does Hangzhou Tigermed Consulting generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | CN¥1.12 Billion | CN¥4.10 Billion | ▲ +14.4% |
| 2024 | 0.24x | CN¥1.10 Billion | CN¥4.61 Billion | ▲ +8.2% |
| 2023 | 0.22x | CN¥1.15 Billion | CN¥5.23 Billion | ▼ -22.7% |
| 2022 | 0.28x | CN¥1.36 Billion | CN¥4.77 Billion | ▼ -37.3% |
| 2021 | 0.45x | CN¥1.42 Billion | CN¥3.14 Billion | ▼ -25.1% |
| 2020 | 0.61x | CN¥998.68 Million | CN¥1.65 Billion | ▲ +135.2% |
| 2019 | 0.26x | CN¥527.56 Million | CN¥2.05 Billion | ▼ -30.6% |
| 2018 | 0.37x | CN¥522.24 Million | CN¥1.41 Billion | ▼ -7.8% |
| 2017 | 0.40x | CN¥314.97 Million | CN¥781.85 Million | ▲ +15.1% |
| 2016 | 0.35x | CN¥191.91 Million | CN¥548.54 Million | ▲ +2.5% |
| 2015 | 0.34x | CN¥185.73 Million | CN¥544.12 Million | ▲ +244.6% |
| 2014 | 0.10x | CN¥43.66 Million | CN¥440.72 Million | ▼ -93.2% |
| 2013 | 1.46x | CN¥77.10 Million | CN¥52.87 Million | ▲ +274.9% |
| 2012 | 0.39x | CN¥14.98 Million | CN¥38.52 Million | ▼ -59.1% |
| 2011 | 0.95x | CN¥38.69 Million | CN¥40.73 Million | ▼ -13.8% |
| 2010 | 1.10x | CN¥26.59 Million | CN¥24.12 Million | ▲ +16.1% |
| 2009 | 0.95x | CN¥21.95 Million | CN¥23.13 Million | — |